Skip to main content
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.300
+0.090 (2.14%)
At close: Nov 13, 2026, 4:00 PM EST
4.360
+0.060 (1.40%)
After-hours: Nov 13, 2026, 7:25 PM EST

Atea Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
345279283254401743
Market Cap Growth
26.28%-1.43%11.19%-36.48%-46.08%-78.48%
Enterprise Value
154-49-198-338-261-96
Last Close Price
4.303.573.353.054.818.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----6.13
Forward PE
-4.424.424.424.424.42
PS Ratio
-----2.11
PB Ratio
1.971.010.650.460.631.05
P/TBV Ratio
1.971.010.650.460.631.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.010
Debt / EBITDA Ratio
-----0.00
Net Debt / Equity Ratio
-1.09-1.09-1.03-1.04-1.00-1.08
Net Debt / EBITDA Ratio
1.111.683.444.795.81-5.52
Net Debt / FCF Ratio
1.362.283.346.745.248.78
Asset Turnover
-----0.43
Quick Ratio
7.647.5924.4418.0435.0013.44
Current Ratio
8.007.8224.8518.2435.7713.58
Return on Equity (ROE)
-63.24%-44.34%-33.88%-22.74%-17.16%19.27%
Return on Assets (ROA)
-39.51%-28.75%-15.60%-11.94%-9.65%10.57%
Return on Capital Employed (ROCE)
-97.80%-65.10%-29.60%-21.40%-17.10%19.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-45.52%-56.77%-59.51%-53.42%-28.93%16.31%
FCF Yield
-40.71%-47.34%-47.89%-33.56%-30.68%-11.71%
Buyback Yield / Dilution
4.44%3.29%-1.05%-0.17%5.67%-308.70%
SEC Filings: 10-K · 10-Q